The IMMUNO-PROT consortium in the Netherlands is offering five fully funded PhD positions for talented biomedical researchers interested in advancing the field of molecular and immune radiation oncology. These positions focus on proton therapy, a cutting-edge approach in cancer treatment, and provide an opportunity to contribute to innovative research at the intersection of oncology, immunology, and radiation science. The research will be conducted at leading Dutch institutions, including the University Medical Center Groningen, under the supervision of Professor Rob Coppes and other experts in the field.

Successful candidates will join a collaborative and multidisciplinary environment, working alongside scientists and clinicians to explore the molecular and immune mechanisms underlying proton therapy and its impact on cancer treatment. The program is designed for individuals with a strong background in biomedical sciences, biology, or related disciplines, and offers comprehensive training in advanced research techniques relevant to oncology and radiation therapy.

Funding for these positions is fully provided by the IMMUNO-PROT consortium, covering salary/stipend and likely tuition and research expenses. The positions are ideal for motivated researchers aiming to push the boundaries of cancer research and make significant contributions to the field of radiation oncology.

Applicants should hold a relevant master's degree and demonstrate a keen interest in molecular and immune aspects of oncology. Experience in oncology, radiation therapy, or immunology is advantageous. For more information and application instructions, candidates are encouraged to visit the LinkedIn announcement or contact the University Medical Center Groningen.